← Leaderboards
Jennifer W Tidey
Brown University
$18,345,955
Attributed
$19,740,948
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,740,948 · 12
By mechanism
U54$6,861,060 · 2
P20$5,644,795 · 3
R01$3,327,850 · 2
T32$1,698,695 · 1
R21$1,117,257 · 3
U01$1,091,291 · 1
Top collaborators
- Damaris J. Rohsenow5 shared
- Patricia Ann Cioe2 shared
Most similar at Brown University
Same institution · by research overlap
- Rachel Denlinger-Apte$1,481,039
- Zhijin Jean Wu$6,938,225
- Benjamin Raphael$12,417,698
- Suzanne M Colby$6,872,995
- Damaris J. Rohsenow$24,046,751
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignSchizophreniaNicotineInnovationResponseCigarette SmokingGeneral PopulationCigaretteSmokerRandomizedCravingTobaccoAbstinenceParticipantBiological MarkersSmokeAddictionSmoking CessationLaboratoriesBehavioralBiologicalSmokingWithdrawalFunding
Grant awards (43)
Clinical Laboratory Core (CLC)$778,545
P20 · FY2025 · GM · contact PI
Substance Abuse Intervention Outcome Research Training$435,325
T32 · FY2025 · DA · contact PI
Clinical Laboratory Core (CLC)$808,072
P20 · FY2024 · GM · contact PI
Substance Abuse Intervention Outcome Research Training$222,595
T32 · FY2024 · DA · contact PI
Clinical Laboratory Core$885,337
P20 · FY2023 · GM · contact PI
Substance Abuse Intervention Outcome Research Training$413,458
T32 · FY2023 · DA · contact PI
Low Nicotine Content Cigarettes in Vulnerable Populations: Affective Disorders$734,543
U54 · FY2022 · DA · contact PI
Clinical Laboratory Core$635,387
P20 · FY2022 · GM · contact PI
Substance Abuse Intervention Outcome Research Training$321,434
T32 · FY2022 · DA
Low Nicotine Content Cigarettes in Vulnerable Populations: Affective Disorders$734,543
U54 · FY2021 · DA · contact PI
Clinical Laboratory Core$657,163
P20 · FY2021 · GM · contact PI
Substance Abuse Intervention Outcome Research Training$305,883
T32 · FY2021 · DA
Clinical Laboratory Core$815,391
P20 · FY2020 · GM · contact PI
Low Nicotine Content Cigarettes in Vulnerable Populations: Affective Disorders$734,543
U54 · FY2020 · DA · contact PI
Clinical Laboratory Core$764,901
P20 · FY2019 · GM · contact PI
Low Nicotine Content Cigarettes in Vulnerable Populations: Affective Disorders$734,956
U54 · FY2019 · DA · contact PI
Health Effects of the Standardized Research E-Cigarette for Harm Reduction in Smokers with HIV$540,349
U01 · FY2019 · DA
Alterations and Renovations$299,999
P20 · FY2019 · GM · contact PI
Low Nicotine Content Cigarettes in Vulnerable Populations: Affective Disorders$758,793
U54 · FY2018 · DA · contact PI
Health Effects of the Standardized Research E-Cigarette for Harm Reduction in Smokers with HIV$550,942
U01 · FY2018 · DA
Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia$236,307
R21 · FY2017 · DA · contact PI
VERY LOW NICOTINE CIGARETTES IN SMOKERS WITH SCHIZOPHRENIA$1,823,557
U54 · FY2015 · DA · contact PI
VERY LOW NICOTINE CIGARETTES IN SMOKERS WITH SCHIZOPHRENIA$530,372
U54 · FY2014 · DA · contact PI
VERY LOW NICOTINE CIGARETTES IN SMOKERS WITH SCHIZOPHRENIA$266,554
U54 · FY2013 · DA · contact PI
Acute Effects of Exercise in Smokers with Schizophrenia$233,700
R21 · FY2013 · DA · contact PI
VERY LOW NICOTINE CIGARETTES IN SMOKERS WITH SCHIZOPHRENIA$264,012
U54 · FY2012 · DA · contact PI
Acute Effects of Exercise in Smokers with Schizophrenia$202,500
R21 · FY2012 · DA · contact PI
VERY LOW NICOTINE CIGARETTES IN SMOKERS WITH SCHIZOPHRENIA$279,187
U54 · FY2011 · DA · contact PI
Smoking abstinence and lapse effects in smokers with schizophrenia and controls$202,500
R21 · FY2010 · DA · contact PI
Biological and Behavioral Mechanisms of Smoking in Schizophrenia$264,778
R01 · FY2009 · DA · contact PI
Smoking abstinence and lapse effects in smokers with schizophrenia and controls$242,250
R21 · FY2009 · DA · contact PI
Biological and Behavioral Mechanisms of Smoking in Schizophrenia$264,778
R01 · FY2008 · DA · contact PI
Biological and Behavioral Mechanisms of Smoking in Schizophrenia$269,544
R01 · FY2007 · DA · contact PI
Biological and Behavioral Mechanisms of Smoking in Schizophrenia$314,583
R01 · FY2006 · DA · contact PI
Incentives Plus Bupropion for Smoking in Schizophrenics$308,838
R01 · FY2006 · DA · contact PI
Incentives Plus Bupropion for Smoking in Schizophrenics$316,270
R01 · FY2005 · DA
Incentives Plus Bupropion for Smoking in Schizophrenics$310,000
R01 · FY2004 · DA
Transdermal Nicotine and Bupropion-SR in Schizophrenics$235,500
R01 · FY2004 · DA
Incentives Plus Bupropion for Smoking in Schizophrenics$6,270
R01 · FY2004 · DA
Incentives Plus Bupropion for Smoking in Schizophrenics$343,215
R01 · FY2003 · DA
Transdermal Nicotine and Bupropion-SR in Schizophrenics$235,500
R01 · FY2003 · DA
Transdermal Nicotine and Bupropion-SR in Schizophrenics$235,500
R01 · FY2002 · DA
Transdermal Nicotine and Bupropion-SR in Schizophrenics$223,074
R01 · FY2001 · DA